Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing enabling technology, and Charles River Laboratories (Charles River), a global industry-leading drug discovery, preclinical ...
Just a few months after the reveal of Ori Biotech’s automated cell and gene therapy manufacturing platform IRO, the technical ...
Charles River generated best-in-class data with Kytopen's Flowfect™ technology in comparative study. The study using CRISPR/Cas9 TRAC gene knockout experiments in primary T cells revealed that the ...
Charles River Laboratories (NYSE: CRL) is reducing its workforce by about 3% as part of broader cost-cutting efforts. The ...
Charles River Laboratories International is cutting over 600 jobs, citing softening demand from pharmaceutical clients.